As of Nov 19, 2026, 0 of 2 active firms rate ACLS a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ACLS EPS & revenue forecast
EPS · NEXT QUARTER
$1.44
Range $1.37 – $1.52 · 5 analysts · +101% YoY
Next period, 5 analysts expect Axcelis Technologies Inc to earn $1.44 a share (range $1.37 – $1.52), versus $0.72 a year earlier. Full-year consensus is $4.54, growing to $6.20 the year after.
REVENUE · NEXT QUARTER
$274.4M
Range $270.0M – $277.0M · 5 analysts · +1% YoY
Revenue is expected to reach $274.4M (range $270.0M – $277.0M), +1.0% year-over-year. Full-year consensus is $927.0M, rising to $1.1B next year.
Top analysts covering Axcelis Technologies Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ACLS.
#1
Charles Shi
Needham · Rank #66
Neutral
$158.00+56.5% to target
Overall win rate
53%
+ Follow
#2
Mark Miller
Benchmark · Rank #123
Buy
$105.00+4.0% to target
Overall win rate
47%
+ Follow
#3
TD
Thomas Diffely
DA Davidson · Rank #135
Buy
$110.00+8.9% to target
Overall win rate
52%
+ Follow
#4
Craig Ellis
B. Riley Securities · Rank #213
Buy
$180.00+78.3% to target
Overall win rate
41%
+ Follow
#5
Christian Schwab
Craig-Hallum · Rank #348
Buy
$105.00+4.0% to target
Overall win rate
41%
+ Follow
ACLS stock forecast FAQ
What is ACLS's average 12-month price target?+
The 2 active firms with a live target average $123.50 for Axcelis Technologies Inc over the next 12 months, ranging from a $156.00 high to a $91.00 low, as of Nov 19, 2026.
Is ACLS stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 1 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ACLS?+
The Street-high target is $156.00 (B of A Securities), and the Street-low is $91.00 (B. Riley Securities). The average of all 2 active-firm targets is $123.50.
How many active Wall Street firms cover ACLS?+
2 active firms have a recognized rating on Axcelis Technologies Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ACLS?+
Among analysts who currently cover ACLS, Charles Shi of Needham has the strongest overall Quantellect track record (Rank #66). Their current call is Neutral with a $158.00 target.
What is Axcelis Technologies Inc's projected EPS for next quarter?+
The consensus estimate is $1.44 per share (range $1.37 – $1.52) across 5 analysts. Full-year EPS is projected at $4.54, rising to $6.20 the following year.
How much revenue is Axcelis Technologies Inc expected to report next quarter?+
Consensus revenue is $274.4M (range $270.0M – $277.0M). Full-year revenue is projected at $927.0M, growing to $1.1B next year.
Have analysts been upgrading or downgrading ACLS lately?+
As of Nov 19, 2026, 0 of 2 active firms rate ACLS a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ACLS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.